IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10660888 B1

PDFFull Text
Date of Patent:
May. 26, 2020

Filed:

Dec. 05, 2018

Aminoheteroaryl benzamides as kinase inhibitors

Applicant:

Novartis Ag, Basel, CH;

Inventors:

Jeffrey T. Bagdanoff, North Reading, MA (US);

Yu Ding, Union City, CA (US);

Wooseok Han, San Ramon, CA (US);

Zilin Huang, Foster City, CA (US);

Qun Jiang, Suzhou, JP;

Xianming Jin, San Ramon, CA (US);

Xiang Kou, Shanghai, CN;

Patrick Lee, Walnut Creek, CA (US);

Mika Lindvall, Oakland, CA (US);

Zhongcheng Min, Shouzhou/ Jiangsu Province, CN;

Yue Pan, Lexington, MA (US);

Sabina Pecchi, Oakland, CA (US);

Keith Bruce Pfister, San Ramon, CA (US);

Daniel Poon, Piedmont, CA (US);

Vivek Rauniyar, Cambridge, MA (US);

Xiaojing Michael Wang, Livermore, CA (US);

Qiong Zhang, Shanghai, CN;

Jianguang Zhou, Shanghai, CN;

Shejin Zhu, Dublin, CA (US);

Assignee:

NOVARTIS AG, Basel, CH;

Attorney:

Scott W. Reid

Primary Examiner:

Zinna Northington Davis

Int. Cl.
CPC ...
A61K 31/497 (2006.01); C07D 213/73 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 403/06 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/4965 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); A61K 31/553 (2006.01); A61K 45/06 (2006.01); C07D 241/20 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 413/14 (2006.01); C07D 498/04 (2006.01); A61K 31/44 (2006.01); A61K 31/4433 (2006.01); A61K 31/5355 (2006.01);
U.S. Cl.
CPC ...
A61K 31/497 (2013.01); A61K 31/44 (2013.01); A61K 31/4433 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/4965 (2013.01); A61K 31/506 (2013.01); A61K 31/5355 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); C07D 213/73 (2013.01); C07D 241/20 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 413/14 (2013.01); C07D 498/04 (2013.01); A61K 2121/00 (2013.01);
Abstract

The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.

Find Patent Forward Citations

Loading…